Because IL-4, IL-5, and IL-13 is related to in increased IgE production in AD patients, PT may lower serum IgE level by suppressing the synthesis of Th2 cytokine (Fig. 3D) 21. The gene discussed is IL5; the disease is Alzheimer disease.